IL-33 has previously been reported its pathological roles in RA [29] and activation of IL33R+ T cells has been shown to increase the incidence of adjuvant-free CIA driven by Gal-COL2-specific T cells [30]. Here, GAL is linked to rheumatoid arthritis.